+44 1223 790975
Spanish 
Chinese 
Russian 
German 
French 
Japanese 
Portuguese 
Hindi Review Article
Alzheimer's Disease Pathology and Oxidative Stress: Possible Therapeutic Options
Tiwari SC* and Soni RM
Department of Geriatric Mental Health, King George’s Medical University UP, India
- Corresponding Author:
- Dr. S. C. Tiwari
Professor and Head, Department of Geriatric Mental Health
King George’s Medical University UP, Lucknow: 226003, India
Tel: +91-9415011977
E-mail: sarvada1953@gmail.com
Received date: August 06, 2014; Accepted date: October 10, 2014; Published date: October 20, 2014
Citation: Tiwari SC, Soni RM (2014) Alzheimer’s Disease Pathology and Oxidative Stress: Possible Therapeutic Options. J Alzheimers Dis Parkinsonism 4:162. doi: 10.4172/2161-0460.1000162
Copyright: © 2014. Tiwari SC et al.This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Abstract
Alzheimer’s disease (AD) is one of the most common causes for the development of Dementia in the elderly. In past two decades there has been abundant research in pathogenesis of AD and possible prevention and treatment. Research evidences have suggested the major role of oxidative stress in the pathogenesis of AD. Sources of this stress are disruption of homeostasis of metals, mitochondrial dysfunction, genetic mutations, β Amyloid accumulation, hyperphosphorylation of tau and inflammation. Oxidative damage found in AD occurs as a result of advanced glycation end products, nitration, lipid peroxidation adduction products, carbonyl modified neurofilament protein and free carbonyls. All the products, discussed above have been considered as blood biomarkers for early diagnosis of AD. Various antioxidant therapies have been identified and studied for prevention and possible treatment of AD, based on role of oxidative stress in pathogenesis of AD. In this review we briefly discuss about the sources of oxidative stress and pathogenesis of AD, along with various newer and older antioxidant therapeutic options.
